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Abstract
This chapter is presented to depict the chance of marine polysaccharides satisfying the 
properties of good pharmaceutical excipients and the potential of that could be utilized 
as multifunctional pharmaceutical excipients in the pharmaceutical solid dosage form 
manufacturing as fillers, diluents/vehicles, binders, glidants, binders and disintegrants, 
and so on. In addition, this chapter discusses the use of marine polysaccharide holding a 
specific pharmacological activity in the formulation/dosage form, which is used for the 
same aliment/disease.
Keywords: marine polysaccharide, pharmaceutical excipients, bioavailability, drug 
delivery, dissolution, disintegrants, pharmacological activity
1. Introduction
Drugs, which are obtained from plants, animals, marine source or minerals, are not very often 
administered in their pure form. Before releasing into the market, these drugs are combined 
with a variety of inert substances (excipients/adjuvants) and modified into a dosage form, 
which is convenient to be administered by a specified route [1]. Similar to the drugs, these 
excipients are also obtained from many sources, namely natural, synthetic sources. Nowadays, 
the naturally obtained excipients have shown more interest due to the various advantages like 
low cost, biocompatibility, biodegradability, non-toxicity, easy availability, eco-friendly pro-
cessing, superior patient tolerance and acceptance [2]. Before, it was thought that the thera-
peutic reaction to a drug is a characteristic of its inherent pharmacological action. However, 
nowadays, it is much implicit that the dose-response connection obtained after drug adminis-
tration by various routes—for example, oral and parenteral—is not identical. The difference is 
also observed when the same medicine is administered as dissimilar dosage forms or similar 
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formulations produced by dissimilar manufacturers, which in turn depends upon the physi-
cal, chemical properties of the drug, the excipients present in the formulation, the technique 
of formulation and the way of administration [1].
Natural marine origins are among the most widely used excipients in the formulation of dif-
ferent dosage forms. A number of marine-based polysaccharides, such as agar, alginate, car-
rageenan, fucoidan, chitosan and hyaluronan are utilized in pharmaceutical dosage form as 
binders, vehicles, disintegrating agents, gelling agents and drug release sustaining agents [3].
The purpose of this review is to discuss potential pharmaceutical formulation development 
applications of marine polysaccharides, with a special emphasis in multifunctional excipients 
development for enhancing bioavailability, drug delivery applications. In addition, this review 
discusses the use of marine polysaccharide holding a specific pharmacological activity in the 
formulation/dosage form, which is used for the same aliment/disease, for example, incorpo-
rating the marine polysaccharide having anti-cancer activity in anti-cancer drug formulation 
as excipients. In fact, data has added that such excipients operate on well-distinct biological 
pathways and receptors in order to implement their valuable properties. If additives that work 
on several cancer pharmacological pathways or receptors targets are jointed together in con-
centrations that are at and/or more than their recommended levels, then there is a possibility 
exists that such a formulated dosage form may offer “standalone” control of cancer.
2. Marine polysaccharides, as multifunctional pharmaceutical excipients
A drug injected intravascularly (I.V/I.A) directly enters the blood and produces its pharmaco-
logical effects. The majority of drugs are administered extravascularly, usually through oral 
route. If anticipated to act systemically, such drugs can produce their pharmacological actions 
only when they come into the blood circulation from their site of application. In order to reach 
the blood circulation, orally administered formulation must disintegrate, deaggregate and 
dissolution of the drug in the aqueous fluid at the absorption site must occur [4]. If the drugs 
are not hydrophilic in nature, the absorption process of drugs like these is usually dissolution 
rate-limited (Figure 1).
Better absorption can be achieved by altering the characteristics of the dosage form using 
pharmaceutical excipients. Moreover, pharmaceutical excipients help in the manufacturing 
process by serving as a binder, diluents, wetting agent, filling agent, disintegrating agents, 
dissolution enhancers, and so on. [3]. Now their increasing demands and expectations 
Figure 1. The two rate-determining steps in the absorption of orally administered dosage form.
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with regard to quality have stimulated the development of new additives characterized by 
advanced assay and lesser content of impurities. Quality of formulation does depend on the 
quality of excipient [4]. The purpose of this study is to give a scope for the researchers to 
try and develop a formulation that is made up of just the drug and natural marine polysac-
charides. This review is done to depict the chance of some marine polysaccharides satisfying 
the properties of good pharmaceutical excipients if the stability of them has been explored 
sufficiently.
2.1. As binder
Marine polysaccharides can serve as a good binder in the production of tablets by the wet 
granulation method of manufacture. In this role, binders are either added as a solution or 
as a solid into the powder mix (following which the granulating fluid, typically water, is 
added). Due to the high concentration of hydroxyl groups in the polysaccharide, generally 
have a high water-binding capacity that makes wet granulation easier [5]. The responsi-
ble bio-adhesives marine polysaccharides have extraordinarily high cohesive strength and 
binding strength to the solid surfaces, enabling the API to remain attached under tensional 
conditions.
2.2. As diluents
Marine polysaccharides can be employed as diluents/fillers in the formulation of tablets (by 
all methods) to increase the mass of the solid dosage forms that hold a low concentration of 
therapeutic agent and thereby render the manufacturing process more reliable and repro-
ducible [6]. For example, chitin and chitosan are used as a diluent or filler and as a binder 
in direct compression of tablet processing, as a disintegrant, and so on. Chitin and chitosan 
have a lowest bulk and tapped density that cause good flow as well as compaction during 
filling and tablet compression processing. Figure 2 shows the structure of cellulose chitin and 
chitosan.
Figure 2. Structure of cellulose, chitin and chitosan.
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Figure 3. Disintegrants facilitating the breakdown of the tablet into granules.
2.3. As disintegrants
Disintegrants are materials added to the dosage forms that enhance the breakup or disinte-
gration of tablet formulations into smaller particles that dissolve faster than in the absence 
of disintegrants. These materials have the main role to oppose the efficiency of tablet binder 
and physical forces that behave under compression to form the tablets. Tablet disintegrant 
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usually considered as the rate determining step (RDS) in a faster drug release. Marine poly-
saccharides may behave as a good disintegrating agent by increasing the porosity, wettability 
and wicking or capillary action and operate by swelling in the presence of aqueous fluids in 
tablet formulations to facilitate the breakdown of the tablet into granules upon entry into the 
stomach [7] (Figure 3).
2.4. As dissolution enhancers
Marine polysaccharides may serve as a dissolution enhancer for the poor soluble drug. These 
powders can reduce cohesive forces holding a tablet dosage form together and induce the 
breakup into smaller granules, thus increasing the effective surface area for dissolution (Figure 4).
2.5. As drug delivery carriers
Marine polysaccharides have been widely used to synthesize drug delivery carriers. They are 
bio-compatible, non-toxic and bio-degradable and stimuli-responsive makes marine polysac-
charides appropriate sources for the building of complex loading devices with a release that 
can be effectively controlled [4]. Table 1 shows the compilation of marine polysaccharides 
utilized as drug delivery carriers, and Figure 5 illustrates the mechanisms of various marine 
polysaccharide carriers and its method of preparation.
Drug delivery devices can be constructed using various methods and can be synthesized in a 
variety of shapes, such as hydro gels, micro or nanoparticles and capsules, capable of protecting 
a variety of bioactive agents such as proteins and nucleic acids.
Figure 4. Dissolution enhancer facilitating dissolution for the poor soluble drug.
Marine Polysaccharides as Multifunctional Pharmaceutical Excipients
http://dx.doi.org/10.5772/66191
133
S. no Name of marine polysaccharide Source Drug delivery use
1. Alginate Brown sea weed Excipient, stabilizer [8], hydrogel matrices, beads, particles [9–12], micro 
particles [13, 14]
2. Carrageenans Red algae Tablet compressor [15], controlled release (temperature sensitive) [16], |fast 
release [17], sustained release [18] (Ph sensitive)
3. Fucoidans Brown algae Microspores, fucospheres [19], insulin controlled release [20],  
nano-particles [21]
4. Ulvans Green algae Cosmetic delivery [22], nano-fibres (tissue engineering and regenerative 
medicine) [23], hydrogel [24]
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S. no Name of marine polysaccharide Source Drug delivery use
5. Chitosans Marine animal (chitin) Nano particles, beads of capsules for controlled release, membranes, films and 
scaffolds for tissue engineering and regenerative medicine [25], stabilization, 
acceleration (release), sustained release [26]
6. Hyaluronan Marine animal 
(glycosaminoglycans)
Hydrogels [27], micro [28], nano particles [29], coating material [30], 
liposomes [31]
7. Chondroitin sulfate Marine animals (whale and shark) Controlled release [32], anti-cancer drug delivery [33]
8. Dermatan sulfate Ray skin (glycosaminoglycans) Stabilizer for growth factor, cytokines [34]
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S. no Name of marine polysaccharide Source Drug delivery use
9. Heparan sulfate Ray skin (glycosaminoglycans) Cancer treatment [35]
10. Keratan sulfate Ray skin (glycosaminoglycans)
11. Agarose Red algae Hydrogels [36]
Table 1. Compilation of marine polysaccharides utilized as drug delivery carriers.
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3. Pharmacological activity of marine polysaccharides  
and potential possibilities of standalone effects when incorporating  
as excipients
Marine polysaccharides stand for a number of abundant bio-active substances in marine 
organisms. In fact, numerous marine macro- and microorganisms are good quality posses-
sions of carbohydrates with miscellaneous applications due to their bio-functional efficacies. 
By involving on cell propagation and cycle, and by modulating metabolic pathways, marine 
polysaccharides have numerous pharmacological efficacies, such as antioxidative, antibacte-
rial, antiviral, immuno-stimulatory, anticoagulant and anticancer effects. Besides the polysac-
charides, monosaccharides are useful for humans and can cure many diseases, mainly those 
linked to metabolism deficiency such as diabetes.
There has been growing facts in recent years that pharmaceutical additives may not be harm-
less, “inert” components of a formulation, but may hold either “stand alone” pharmacological 
activity or may act to modify the pharmacological efficacy of the API. Because most excipients 
have historically derived from food or food products, they have been assigned—and in most 
cases, experimentally confirmed—to have widespread pharmacological activity based on the 
ingestion of those products. Marine polysaccharides holding a specific pharmacological activ-
ity can be incorporated as an excipient in the formulation/dosage form, which is used for the 
same aliment/disease. Table 2 shows the pharmacological activity of marine polysaccharides, 
and Figure 6 illustrates the mechanism of action involved in the pharmacological activity of 
marine polysaccharides.
Figure 5. Illustrating the mechanism of various marine polysaccharide carriers and their method of preparation.
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Figure 6. Illustrating the mechanism of action involved in the pharmacological activity of marine polysaccharides.
S. no Marine polysaccharide Source Pharmacological activity
1. Alginate Brown sea weed
2. Carrageenans Red algae Anticoagulant [37], Anti-tumour [38] , Immuno-modulator 
[39], anti-hyperlipidaemic [40], Antioxidant [41], 
Antibacterial, viral [42], bird flu, dengue, Hepatitis A, HIV 
[43]
3. Fucoidans Brown algae Anti-tumour [44, 45], anti-thrombin [19], anti-coagulant, 
anti-inflammatory, anti-adhesive and anti-viral [46], burn 
treatment [47]
4. Ulvans Green algae Anti-viral, anti-oxidant, anti-coagulant, anti-tumour,  
anti-hyperlipidaemic and immune system enhancer [48]
5. Chitosans Marine animal (chitin) Antimicrobial [49], anti-tumour and inflammatory [50]
6. Hyaluronans Marine animal 
(glycosaminoglycans)
Wound treatment [51], supplement for arthritis [52]
7. Chondroitin sulfate Marine animals (whale  
and shark)
Anti-coagulant [53], supplement for arthritis [53]
8. Dermatan sulfate Ray skin 
(glycosaminoglycans)
Anti-coagulant [54]
9. Heparan sulfate Ray skin 
(glycosaminoglycans)
10. Keratan sulfate Ray skin 
(glycosaminoglycans)
Anti-adhesive, osteoarthritis [54]
11. Agarose Red algae Glucose intolerance in type 2 diabetes mellitus, weight loss, 
anti-bacterial [40]
Table 2. Pharmacological activity of marine polysaccharides.
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However, the majority of the pathways or modes of action has not been revealed in humans. In 
addition, fairly only some have been investigated in-vitro. These in-vitro findings are unable 
to extrapolate into their actions in-vivo in humans. There should be well-controlled human 
clinical investigations using such a mixture of additives are essential prior to any rationaliza-
tion for effectiveness can be asserted.
Ideation of using “marine polysaccharide bio-active excipients” is possible for diseases that 
are chronic in nature and for whom gradual and lasting beneficial efficacy may be observed 
from the modulation of signalling pathways that direct to incremental but visible improve-
ments in the quality of life. Such “marine polysaccharide bio-active excipients” may not be 
efficient for acute diseases for which radical interventions are necessary.
4. Conclusion
Marine polysaccharides have a huge potential as multifunctional pharmaceutical excipients 
for commercial needs. However, there is a need to characterize, check compatibility of these 
polysaccharides to produce pharmaceutical grade additives that could find the utility in drug 
dosage form. In addition, research is warranted in pharmacodynamic interaction of these 
marine polysaccharides and particular drug when using for same aliments.
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